Reducing antipsychotic-induced weight gain in schizophrenia: A double-blind placebo-controlled study of reboxetine-betahistine combination

Michael Poyurovsky*, Camil Fuchs, Artashez Pashinian, Adva Levi, Ronit Weizman, Abraham Weizman

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Reducing antipsychotic-induced weight gain in schizophrenia: A double-blind placebo-controlled study of reboxetine-betahistine combination'. Together they form a unique fingerprint.

Medicine & Life Sciences